• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Edit Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock (NQ:CYCCP)

5.050 UNCHANGED
Last Price Updated: 3:01 PM EDT, Sep 11, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 5.050
Bid (Size) 4.750 (1)
Ask (Size) 5.500 (10)
Prev. Close 5.050
Today's Range 5.050 - 5.050
52wk Range 5.050 - 5.050
Shares Outstanding N/A
Dividend Yield 5.94%
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Bio Green Med Solution, Inc. Announces Closing of Strategic Acquisition of Fitters Sdn. Bhd.
September 12, 2025
From Bio Green Med Solution, Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
September 08, 2025
 
Via Benzinga

Performance

More News

Read More
News headline image
Cyclacel Pharmaceuticals Reports Second Quarter Financial Results and Provides Business Update
August 13, 2025
From Cyclacel
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
July 24, 2025
Via Benzinga
News headline image
Cyclacel Pharmaceuticals Announces Stock Split
July 02, 2025
From Cyclacel
Via GlobeNewswire
News headline image
Cyclacel Pharmaceuticals Announces $3 Million Private Placement Offering of Convertible Preferred Stock
June 20, 2025
From Cyclacel
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
June 04, 2025
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
June 03, 2025
Via Benzinga
News headline image
Cyclacel Pharmaceuticals Reports Fourth Quarter Financial Results and Provides Business Update
April 02, 2025
From Cyclacel
Via GlobeNewswire
News headline image
Cyclacel Pharmaceuticals Announces $1 Million Private Placement Offering of Convertible Preferred Stock
March 24, 2025
From Cyclacel
Via GlobeNewswire
News headline image
Cyclacel Pharmaceuticals Announces Closing of a Change of Control Transaction and Appointment of New Executive Leadership
February 27, 2025
From Cyclacel
Via GlobeNewswire
News headline image
Cyclacel Pharmaceuticals Announces Agreement for the Acquisition of Preferred Stock by David Lazar
January 03, 2025
From Cyclacel
Via GlobeNewswire
News headline image
Cyclacel Pharmaceuticals Announces Its Exploration of Potential Strategic Alternatives and Reduction of Operating Costs
December 05, 2024
From Cyclacel
Via GlobeNewswire
News headline image
Cyclacel Pharmaceuticals Announces Closing of Exercise of Warrants for $2.1 Million Gross Proceeds
November 14, 2024
From Cyclacel
Via GlobeNewswire
News headline image
Cyclacel Pharmaceuticals Announces Exercise of Warrants for $2.1 Million Gross Proceeds
November 13, 2024
From Cyclacel
Via GlobeNewswire
News headline image
Cyclacel Pharmaceuticals Reports Third Quarter Financial Results and Provides Business Update
November 12, 2024
From Cyclacel
Via GlobeNewswire
News headline image
Cyclacel Pharmaceuticals Announces That Nasdaq Granted an Extension to Regain Compliance With the Equity Standard Rule
October 24, 2024
From Cyclacel
Via GlobeNewswire
News headline image
Cyclacel Pharmaceuticals Reports New Clinical Data from Ongoing, Phase 2 Study of Oral Fadraciclib at the 2024 EORTC-NCI-AACR Symposium
October 23, 2024
From Cyclacel
Via GlobeNewswire
News headline image
Cyclacel Pharmaceuticals to Present New Clinical Data From Phase 2 Study of Oral Fadraciclib at the 2024 EORTC-NCI-AACR Symposium
October 09, 2024
From Cyclacel
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
October 04, 2024
Via Benzinga
News headline image
Cyclacel Pharmaceuticals Announces Completion of Enrollment in the Biomarker-Enriched Patient Cohort of Its Phase 2 Study
September 25, 2024
From Cyclacel
Via GlobeNewswire
News headline image
Cyclacel Pharmaceuticals Announces Participation at the H.C. Wainwright 26th Annual Global Investment Conference
September 04, 2024
From Cyclacel
Via GlobeNewswire
News headline image
Cyclacel Pharmaceuticals Confirms It Has Filed an Appeal to Nasdaq Staff Delisting Letter
September 03, 2024
From Cyclacel
Via GlobeNewswire
News headline image
Cyclacel Pharmaceuticals Reports Second Quarter Financial Results and Provides Business Update
August 14, 2024
From Cyclacel
Via GlobeNewswire
News headline image
Cyclacel Pharmaceuticals to Release Second Quarter 2024 Financial Results
August 07, 2024
From Cyclacel
Via GlobeNewswire

Frequently Asked Questions

Is Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock publicly traded?
Yes, Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock is publicly traded.
What exchange does Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock trade on?
Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock?
The ticker symbol for Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock is CYCCP on the Nasdaq Stock Market
What is the current price of Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock?
The current price of Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock is 5.050
When was Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock last traded?
The last trade of Cyclacel Pharmaceuticals, Inc. - 6% Convertible Preferred Stock was at 09/11/25 03:01 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap